Variable | CSS | OS | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Univariate analysis | Multivariate analysis | |||||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Age, continuous | 1.01 (0.99–1.03) | 0.282 | 0.99 (0.97–1.02) | 0.641 | 1.03 (1.01–1.04) | 0.011 | 1.02 (0.99–1.04) | 0.159 |
Gender | ||||||||
 Male | 1 | 0.681 | 1 | 0.93 | 1 | 0.827 | 1 | 0.66 |
 Female | 1.11 (0.68–1.80) |  | 1.03 (0.56–1.88) |  | 1.05 (0.67–1.64) |  | 0.89 (0.53–1.50) |  |
Smoking | ||||||||
 No | 1 | 0.171 | 1 | 0.302 | 1 | 0.113 | 1 | 0.119 |
 Yes | 1.37 (0.87–2.14) |  | 1.34 (0.77–2.36) |  | 1.38 (0.93–2.04) |  | 1.46 (0.91–2.34) |  |
Previous hydronephrosis | ||||||||
 No | 1 | 0.115 | 1 | 0.439 | 1 | 0.058 | 1 | 0.149 |
 Yes | 1.47 (0.91–2.38) |  | 1.30 (0.67–2.50) |  | 1.51 (0.99–2.32) |  | 1.51(0.86–2.65) |  |
Previous bladder urothelial carcinoma | ||||||||
 No | 1 | 0.606 | 1 | 0.833 | 1 | 0.926 | 1 | 0.966 |
 Yes | 1.24 (0.54–2.86) |  | 1.23 (0.37–3.48) |  | 0.96 (0.42–2.19) |  | 1.02 (0.39–2.69) |  |
Concomitant bladder urothelial carcinoma | ||||||||
 No | 1 | 0.636 | 1 | 0.712 | 1 | 0.48 | 1 | 0.411 |
 Yes | 1.14 (0.66–1.97) |  | 1.13 (0.60–2.14) |  | 0.83 (0.49–1.41) |  | 0.77 (0.42–1.43) |  |
Laterality | ||||||||
 Left | 1 | 0.512 | 1 | 0.11 | 1 | 0.772 | 1 | 0.23 |
 Right | 0.87 (0.56–1.33) |  | 1.50 (0.91–2.45) |  | 0.95 (0.65–1.38) |  | 1.30 (0.85–1.99) |  |
Tumor location | ||||||||
 Renal pelvis | 1 | 0.029 |  | 0.07 | 1 | 0.4 | 1 | 0.458 |
 Ureter | 1.35 (0.85–2.15) |  | 1.77 (0.93–3.37) |  | 1.15 (0.77–1.72) |  | 1.31 (0.76–2.25) |  |
 Renal pelvis and ureter | 2.61 (1.28–5.34) |  | 2.69 (1.08–6.70) |  | 1.62 (0.79–3.32) |  | 1.63 (0.70–3.78) |  |
Tumor size, continuous | 1.13 (1.03–1.26) | 0.015 | 1.07 (0.95–1.21) | 0.268 | 1.09 (0.99–1.19) | 0.083 | 1.05 (0.94–1.18) | 0.364 |
Tumor focality | ||||||||
 Unifocal | 1 | 0.07 | 1 | 0.871 | 1 | 0.085 | 1 | 0.694 |
 Multifocal | 1.49 (0.97–2.28) |  | 0.96 (0.58–1.60) |  | 1.40 (0.96–2.04) |  | 1.09 (0.70–1.70) |  |
LVI | Â | Â | Â | Â | Â | Â | Â | Â |
 No | 1 | < 0.001 | 1 | 0.003 | 1 | < 0.001 | 1 | 0.002 |
 Yes | 2.20 (1.54–3.13) |  | 2.0 (1.26–3.17) |  | 2.20 (1.50–3.23) |  | 1.88 (1.25–2.83) |  |
Tumor grade | ||||||||
 Low | 1 | < 0.001 |  | < 0.001 | 1 | < 0.001 | 1 | 0.001 |
 High | 11.23 (4.89–25.81) |  | 6.95 (2.87–16.83) |  | 4.03 (2.47–6.56) |  | 2.59 (1.50–4.49) |  |
pT stage | ||||||||
 pT1 | 1 | < 0.001 |  | 0.002 | 1 | < 0.001 | 1 | 0.004 |
 pT2 | 1.91 (0.75–4.84) |  | 1.69 (1.11–2.59) |  | 1.36 (0.69–2.70) |  | 1.40 (0.91–2.14) |  |
 pT3/pT4 | 7.40 (3.55–15.43) |  | 2.83 (1.20–6.66) |  | 4.12 (2.43–6.99) |  | 2.29 (1.21–4.36) |  |
pN stage | ||||||||
 pN0 | 1 | 0.429 | 1 | 0.494 | 1 | 0.785 | 1 | 0.645 |
 pNx | 0.84 (0.55–1.29) |  | 0.84 (0.51–1.38) |  | 0.95 (0.64–1.40) |  | 0.90 (0.59–1.39) |  |
Distal ureter management | ||||||||
 Extravesical | 1 | 0.434 | 1 | 0.277 | 1 | 0.538 | 1 | 0.921 |
 Open intravesical | 1.09 (0.65–1.85) |  | 1.35 (0.75–2.41) |  | 0.77 (0.49–1.22) |  | 0.93 (0.57–1.52) |  |
 Endoscopic | 0.73 (0.36–1.48) |  | 0.74 (0.30–1.84) |  | 0.87 (0.50–1.50) |  | 0.86 (0.41–1.82) |  |
Adjuvant chemotherapy | ||||||||
 No | 1 | < 0.001 | 1 | 0.111 | 1 | < 0.001 | 1 | 0.331 |
 Yes | 2.93 (1.88–4.56) |  | 1.54 (0.90–2.63) |  | 2.13 (1.40–3.22) |  | 1.28 (0.78–2.09) |  |
Type of procedure | ||||||||
 ONU | 1 | 0.191 | 1 | 0.444 | 1 | 0.909 | 1 | 0.17 |
 LNU | 0.67 (0.37–1.22) |  | 1.38 (0.61–3.13) |  | 1.03 (0.65–1.63) |  | 1.61 (0.82–3.17) |  |